[Extramedullary hematopoiesis, a rare complication of sickle cell disease: A six-case series and literature review].

Ugo Boccadifuoco, Geoffrey Cheminet, Benjamin Morino, Jean-Benoît Arlet
{"title":"[Extramedullary hematopoiesis, a rare complication of sickle cell disease: A six-case series and literature review].","authors":"Ugo Boccadifuoco, Geoffrey Cheminet, Benjamin Morino, Jean-Benoît Arlet","doi":"10.1016/j.revmed.2024.12.006","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Extramedullary hematopoiesis (EMH) is very rarely described during sickle cell disease (SCD). Our aim was to describe six cases of EMH occurring in adult SCD patients and to conduct a literature review.</p><p><strong>Methods: </strong>Retrospective, descriptive, and monocentric study, identifying all cases of EMH recorded in our cohort of adult SCD patients, up to April 2024. A literature review via PubMed included thirty-five articles (44 patients).</p><p><strong>Results: </strong>Six patients (4 men, 83.3% with SS genotype [n=5], 1 SC), with a median age of 22 (range 12-64) years at the time of EMH diagnosis were included. Four patients (66.7%) had an aseptic osteonecrosis of the hip. The localization of EMH varied: paravertebral (n=3), peri-articular in the hip (n=1), adrenal (n=1), hepatic (n=1), splenic (n=1) and was similar to the localizations reported in the literature. EMH was symptomatic at diagnosis in half of the cases. The diagnosis was established by histology (n=3/3) and/or typic magnetic resonance imaging (MRI) (n=4/4). The median baseline hemoglobin was 9.1 (extremes 5.8-10.9) g/dL. A watch-and-wait approach was primarily observed.</p><p><strong>Conclusion: </strong>EMH in SCD patients appears to be rare, with varied localizations. Its diagnosis is made with MRI and/or biopsy, and its treatment is not consensual.</p>","PeriodicalId":94122,"journal":{"name":"La Revue de medecine interne","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"La Revue de medecine interne","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.revmed.2024.12.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Extramedullary hematopoiesis (EMH) is very rarely described during sickle cell disease (SCD). Our aim was to describe six cases of EMH occurring in adult SCD patients and to conduct a literature review.

Methods: Retrospective, descriptive, and monocentric study, identifying all cases of EMH recorded in our cohort of adult SCD patients, up to April 2024. A literature review via PubMed included thirty-five articles (44 patients).

Results: Six patients (4 men, 83.3% with SS genotype [n=5], 1 SC), with a median age of 22 (range 12-64) years at the time of EMH diagnosis were included. Four patients (66.7%) had an aseptic osteonecrosis of the hip. The localization of EMH varied: paravertebral (n=3), peri-articular in the hip (n=1), adrenal (n=1), hepatic (n=1), splenic (n=1) and was similar to the localizations reported in the literature. EMH was symptomatic at diagnosis in half of the cases. The diagnosis was established by histology (n=3/3) and/or typic magnetic resonance imaging (MRI) (n=4/4). The median baseline hemoglobin was 9.1 (extremes 5.8-10.9) g/dL. A watch-and-wait approach was primarily observed.

Conclusion: EMH in SCD patients appears to be rare, with varied localizations. Its diagnosis is made with MRI and/or biopsy, and its treatment is not consensual.

髓外造血,镰状细胞病的罕见并发症:六例系列分析和文献复习。
简介:髓外造血(EMH)在镰状细胞病(SCD)中很少被描述。我们的目的是描述6例发生在成年SCD患者中的EMH,并进行文献综述。方法:回顾性、描述性和单中心研究,确定截至2024年4月我们的成年SCD患者队列中记录的所有EMH病例。PubMed的文献综述包括35篇文章(44名患者)。结果:6例患者(男性4例,83.3%为SS基因型[n=5], 1例SC), EMH诊断时中位年龄为22岁(12-64岁)。4例(66.7%)发生髋关节无菌性骨坏死。EMH的定位不同:椎旁(n=3),髋关节关节周围(n=1),肾上腺(n=1),肝脏(n=1),脾脏(n=1),与文献报道的定位相似。半数病例在诊断时有EMH症状。通过组织学(n=3/3)和/或典型磁共振成像(MRI) (n=4/4)进行诊断。中位基线血红蛋白为9.1 g/dL(极值为5.8-10.9)。观察和等待的方法是主要观察到的。结论:SCD患者的EMH罕见,且定位多样。它的诊断是通过MRI和/或活检,其治疗不是双方同意的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信